Clinical Trials

150 enrolled

Ovarian Neoplasms

NCT05763472 2023-03-10

Gen-eva

10 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT04752865 2023-03-01

Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer

Ovarian Neoplasms

NCT05265117 2023-02-17

The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study

310 enrolled

Ovarian Neoplasms

NCT05693974 2023-01-23

Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)

130 enrolled

Ovarian Neoplasms

NCT05693987 2023-01-23

Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study)

248 enrolled

Ovarian Neoplasms

NCT05685524 2023-01-17

Clinical Study of Pan-cancer DNA Methylation Test in Plasma

GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

3,000 enrolled

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT04770376 2022-12-29

Evaluation of the Predictive Value of Blood Levels of Angiopoietin 1 and Endothelial Internal Tunica Cell Kinase 2 in Patients With Ovarian Cancer Treated With Chemotherapy Associated to Bevacizumab

150 enrolled

Ovarian Neoplasms

NCT05642871 2022-12-08

DKI Combined With APT for Post-treatment Assessment of Ovarian Malignancies and Correlation With XRCC2 Gene

2 enrolled

Ovarian Neoplasms

NCT05640024 2022-12-07

Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors

54 enrolled

Ovarian Neoplasms

NCT05576519 2022-10-12

Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Epithelial Ovarian Carcinoma

Ovarian Neoplasms

NCT05537844 2022-09-23

BriTROC-2

250 enrolled

GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05458973 2022-09-13

Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.

100 enrolled

Ovarian Neoplasms

NCT05523804 2022-08-31

GO SOAR2

800 enrolled

Ovarian Neoplasms

NCT05496517 2022-08-11

OCISS

1,000 enrolled

Ovarian Neoplasms

NCT05440578 2022-07-01

First-line Olaparib Combined With Bevacizumab Maintenance Therapy

Ovarian Neoplasms

NCT05410015 2022-06-08

Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian Cancer

300 enrolled

Ovarian Neoplasms

NCT05410028 2022-06-08

New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence

1,000 enrolled

Ovarian Neoplasms

NCT04235556 2022-05-13

PASSION

BreastGastrointestinalGenitourinaryGynecologicThoracic

1,800 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Personal Satisfaction, Prostatic Neoplasms, Stomach Neoplasms, Thoracic Neoplasms

NCT05154474 2022-05-03

SPACE2

BreastClassical hematologyGastrointestinalGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

150 enrolled

Anemia, Refractory, with Excess of Blasts, Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Sarcopenia

NCT05274867 2022-03-11

PROM-OSP

137 enrolled

Ovarian Neoplasms

NCT05255861 2022-02-25

An Exploratory Study of HRD Score in Chinese Ovarian Cancer Patients Benefiting From PARP Inhibitor Targeted Therapy

300 enrolled

Ovarian Neoplasms

NCT05174377 2022-01-25

CADx

600 enrolled

Ovarian Neoplasms

NCT05175326 2022-01-03

Study on the Consistency Evaluation of Organoids Used in the Clinical Treatment of Ovarian Cancer With Anti-tumor Drugs

64 enrolled

Ovarian Neoplasms

NCT05161949 2021-12-17

ATENA

240 enrolled

Endometriosis, Ovarian Neoplasms

NCT05153603 2021-12-10

Outcomes of First-line Olaparib Mono-maintenance therapy-a Multicenter, Retrospective Study Using Data From Real-world Clinical Setting

Ovarian Neoplasms

NCT05081765 2021-10-18

The Effect of Glucose Level and Diabetes Mellitus on Ctrough of Olaparib

40 enrolled

Hyperglycemia, Ovarian Neoplasms

NCT04214964 2021-10-07

Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study

10,000 enrolled